AI-generated summary
The authors report a case study of one patient with limited scleroderma (CREST syndrome) who received 940 nm light therapy on each elbow for 13 weeks, using a pulsed mode on one elbow and a continuous wave mode on the other. They report functional and morphologic improvements, with the best results with the pulsed mode, and no adverse effects.
- Participants
- 1
- Who or what was studied
- One patient with limited cutaneous systemic sclerosis (CREST syndrome) with osteoarticular signs and symptoms
- Wavelengths
- 940 nm
- Limits stated in the abstract
- This is a single-patient case report, so the findings cannot be generalized and no control group was used.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on spiedigitallibrary.org.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 940 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Case report, Low-level laser therapy, Inflammation. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.